Livedoid Vasculopathy: Strong Association With Smoking, Weak Association With Thrombophilia
NCT05878327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2023-05-26
Summary
A screening of patient histories at the clinics of Dermatology of the universities of Zurich, Basel and Bern is performed in order to identify patients with a history of Livedoid vasculopathy. Patients with a history of livedoid vasculopathy are asked to participate in the study. After reading the patient information and if the informed consent is signed patients are included in the study. Patients are questioned about their smoking history and blood is drawn in order to perform a screening for thrombophilia.
Conditions
- Livedoid Vasculitis
Interventions
- OTHER
-
Thrombophilia screening
No intervention. Blood is drawn for analysis.
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Principal Investigators
-
Juerg Hafner, Prof, MD · University Hospital Zurich, Dept. of Dermatology
Eligibility
- Min Age
- 10 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Metabolomic Analysis of Systemic Sclerosis
NCT02298777 ·Status: TERMINATED
-
Evaluation and Treatment of Patients With Dermatologic Diseases
NCT00001506 ·Status: COMPLETED
-
Coagulopathy of Immunodermatologic Diseases
NCT06037187 ·Status: RECRUITING
-
Assessment of Dermatologists at Skin of Color Clinics
NCT03201029 ·Status: COMPLETED
-
Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
NCT01044043 ·Status: COMPLETED
-
Trichoscopy and Systemic Scleroderma
NCT04804930 ·Status: RECRUITING
-
Development and Prevention of Pulmonary Hypertension in Systemic Sclerosis
NCT01840748 ·Status: UNKNOWN
-
Fibroblast Line Evaluation for COL5A eXpression and Thoracic Aortic Aneurysms: in Vitro Characterization of Cutaneous Fibroblasts in Adult Patients
NCT07282717 ·Status: NOT_YET_RECRUITING
-
Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis
NCT02636127 ·Status: COMPLETED ·Phase: NA
-
Nailfold Capillaroscopic Pattern Changes and Its Correlation with Interstitial Lung Disease (ILD) in Systemic Sclerosis (SSc) Patients.
NCT06579651 ·Status: NOT_YET_RECRUITING
-
High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis
NCT00428883 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Early Diagnosis of Pulmonary Hypertension in Patients With Inflammatory Rheumatic Connective Tissue Diseases
NCT01387035 ·Status: RECRUITING
-
ADDICTAO: Psychological and Addictive Profile of Patients With Buerger's Disease
NCT01064206 ·Status: COMPLETED
-
Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis
NCT05273138 ·Status: RECRUITING
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection
NCT04361786 ·Status: COMPLETED
-
A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
NCT03957681 ·Status: COMPLETED ·Phase: PHASE3
-
Defects of Keratinocytes Function in Dermatologic Patients
NCT06324552 ·Status: RECRUITING
-
A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome
NCT05211830 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED
-
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa
NCT05157958 ·Status: RECRUITING ·Phase: PHASE2
-
Gene First Approach to Connective Tissue Disease
NCT04664478 ·Status: COMPLETED
-
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612 ·Status: COMPLETED ·Phase: NA
-
Development and Prevention of Severe Heart Disease in Systemic Sclerosis
NCT01829126 ·Status: UNKNOWN
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3